Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:STML

Stemline Therapeutics (STML) Stock Price, News & Analysis

Stemline Therapeutics logo

About Stemline Therapeutics Stock (NASDAQ:STML)

Advanced Chart

Key Stats

Today's Range
$11.83
$11.83
50-Day Range
$11.83
$11.83
52-Week Range
$3.21
$18.22
Volume
1,084 shs
Average Volume
1.52 million shs
Market Capitalization
$621.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stemline Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

STML Stock News Headlines

Trade These 7 Stocks Under $10 for Huge Profits
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

STML Stock Analysis - Frequently Asked Questions

Stemline Therapeutics Inc (NASDAQ:STML) posted its quarterly earnings data on Thursday, November, 7th. The biopharmaceutical company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($0.42) by $0.08. The biopharmaceutical company had revenue of $13.33 million for the quarter, compared to the consensus estimate of $13.40 million. Stemline Therapeutics had a negative trailing twelve-month return on equity of 48.14% and a negative net margin of 150.30%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stemline Therapeutics investors own include TG Therapeutics (TGTX), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Exelixis (EXEL), Sorrento Therapeutics (SRNE) and ZIOPHARM Oncology (ZIOP).

Company Calendar

Last Earnings
11/07/2019
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:STML
CIK
1264587
Fax
N/A
Employees
92
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$76.82 million
Net Margins
-150.30%
Pretax Margin
N/A
Return on Equity
-48.14%
Return on Assets
-41.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.43
Quick Ratio
7.37

Sales & Book Value

Annual Sales
$43.22 million
Price / Sales
14.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.26 per share
Price / Book
3.63

Miscellaneous

Outstanding Shares
52,511,000
Free Float
N/A
Market Cap
$621.21 million
Optionable
Optionable
Beta
1.78
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:STML) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners